|
Last updated: 28 July 2009 - Next update due: 4 August 2009
| Primary Research |
| Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A (H1N1)v |
Report now available
View the executive summary (pdf format)
You can view the full text from the H1N1 influenza and pandemic flu themed issue 1 publication details page on the HTA website |
| 09/95/01 |
| £179,994 |
| Professor Elizabeth Miller, Health Protection Agency |
| July 2009 |
This study is designed to help the government decide how best to protect the population against the new swine flu virus this winter. For this we need to know which groups in the population are most likely to become infected and to have rapid and accurate ways of monitoring this month by month through the epidemic. This is best done by testing blood samples from representtaive members of the population to see who was susceptible to infection at the start of the epidemic and which groups are at the greatest risk of picking up the infection. We will be using discarded samples from patients which have been taken for routine tests unrelated to swine flu. All testing will be undertaken anonymously and the results cannot be tracked back to the patient. We will make our results available to public health doctors and other experts who are advising the Department of Health on how best to use vaccines when they become available.
|
1. To document the age-specific antibody prevalence to novel influenza H1N1v prior to its arrival in England
2. To measure age-specific incidence of H1N1v during the evolving epidemic
3. To document age-specific antibody prevalence to H1N1v at the end the first wave
|
| Project protocol not available |
|
printer friendly version
Share
